Clinical trial
Comparison the Efficacy Depending on the Order of the Sequential Combination Method Using Sodium Picosulfate and Magnesium Citrate (PMC) and PEG With Ascorbic Acid for Bowel Preparation (The Phase II Prospective Randomized Clinical Trial)
NCT02979223 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison the Efficacy Depending on the Order of the Sequential Combination Method Using Sodium Picosulfate and Magnesium Citrate (PMC) and PEG With Ascorbic Acid for Bowel Preparation (The Phase II Prospective Randomized Clinical Trial)
- Lead sponsor
- National Cancer Center, Korea
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- June 30, 2017
- Enrollment
- 142 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bowel preparation, polyethylene glycol with ascorbic acid, sodium picosulfate and magnesium citrate